ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FF01 | BioTech | Nivolumab - 40mg/4ml | 8332/388 | 120615/1 | OPDIVO | 40mg/4ml | 1 x 4ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | L.L | 10.71 | E1 | Bristol-Myers Squibb Company | USA | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FF01 | BioTech | Nivolumab - 40mg/4ml | 8332 | 120615/1 | OPDIVO | 40mg/4ml | 1 x 4ml | Injectable solution | Infusion | Pacific pharma | Bristol-Myers Squibb Holdings Pharma Ltd Liability Company Manati | USA | 51,234,726 L.L | 10.71 | E1 | Bristol-Myers Squibb Company | USA | 12/12/20 | 0 |